Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Solit

Showing results (1-10 of 352) with videos related to

Pageof 36
Sort By:
Nature Reviews. Genetics|March 25, 2021
Clinical cancer genomic profilingDebyani Chakravarty, David B Solit
Drug Discovery Today|January 15, 2008
Development and application of Hsp90 inhibitorsDavid B Solit, Gabriela Chiosis
Current Topics in Medicinal Chemistry|July 18, 2006
Hsp90: a novel target for cancer therapyDavid B Solit, Neal Rosen
Cancer Discovery|January 10, 2014
Towards a unified model of RAF inhibitor resistanceDavid B Solit, Neal Rosen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2020
Overcoming Adaptive Resistance to KRAS Inhibitors Through Vertical Pathway TargetingRona Yaeger, David B Solit
The New England Journal of Medicine|February 25, 2011
Resistance to BRAF inhibition in melanomasDavid B Solit, Neal Rosen
Current Opinion in Pharmacology|July 23, 2008
Therapeutic strategies for inhibiting oncogenic BRAF signalingEnsar Halilovic, David B Solit
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2012
Will Hsp90 inhibitors prove effective in BRAF-mutant melanomas?Federica Catalanotti, David B Solit
The Journal of Pathology|December 3, 2010
KRAS and BRAF: drug targets and predictive biomarkersEfsevia Vakiani, David B Solit
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2007
Targeting HER2 in prostate cancer: where to next?David B Solit, Neal Rosen
Pageof 36

Showing results (1-10 of 352) with videos related to

Sort By:
Pageof 36
Nature Reviews. Genetics|March 25, 2021
Clinical cancer genomic profilingDebyani Chakravarty, David B Solit
Drug Discovery Today|January 15, 2008
Development and application of Hsp90 inhibitorsDavid B Solit, Gabriela Chiosis
Current Topics in Medicinal Chemistry|July 18, 2006
Hsp90: a novel target for cancer therapyDavid B Solit, Neal Rosen
Cancer Discovery|January 10, 2014
Towards a unified model of RAF inhibitor resistanceDavid B Solit, Neal Rosen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2020
Overcoming Adaptive Resistance to KRAS Inhibitors Through Vertical Pathway TargetingRona Yaeger, David B Solit
The New England Journal of Medicine|February 25, 2011
Resistance to BRAF inhibition in melanomasDavid B Solit, Neal Rosen
Current Opinion in Pharmacology|July 23, 2008
Therapeutic strategies for inhibiting oncogenic BRAF signalingEnsar Halilovic, David B Solit
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2012
Will Hsp90 inhibitors prove effective in BRAF-mutant melanomas?Federica Catalanotti, David B Solit
The Journal of Pathology|December 3, 2010
KRAS and BRAF: drug targets and predictive biomarkersEfsevia Vakiani, David B Solit
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2007
Targeting HER2 in prostate cancer: where to next?David B Solit, Neal Rosen
Pageof 36